News
3 Stocks That Could Double in the Next Few Years
When it comes to growth stocks, you have to understand the risks going in. But there are three growth stocks that I have strong convictions about, and they could produce huge returns for investors.
Stock Market Today: Nvidia Slips but Analyst Upgrades Signal Confidence
Nvidia (NASDAQ: NVDA) closed down 0.2% at $174.98 on Thursday, with trading volume of 135 million shares, below its three-month average of 181 million. The modest decline contrasted with weakness in
Stock Market Today: Nvidia Slides Despite Bullish Analyst Revisions
Nvidia (NASDAQ: NVDA) shares fell 3.5% on Tuesday, closing at $175.64, as tech stocks broadly pulled back following a recent rally. The chipmaker traded 183 million shares, just above its
3 Fantastic Growth Stocks to Buy in August
We're well into the home stretch of 2025. August is more than halfway over. But there's still plenty of time remaining in the year -- and in this month -- to invest in stocks that hold the potential
What AMD and Nvidia Shareholders Should Know About Recent China Updates
In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA) and Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the
ImmuCell Q2 Profit Jumps as Margins Rise
ImmuCell(NASDAQ:ICCC) reported results for the three-month period ended June 30, 2025, on August 14, 2025, highlighting a sharp rebound in profitability with adjusted EBITDA of $1.43 million
What AMD, CoreWeave, and Nvidia Stock Investors Should Know About Recent Updates
In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: AMD), and CoreWeave (NASDAQ: CRWV). To learn more, check out the short video, consider
TuHURA R&D Jumps 75% in Q2
TuHURA Biosciences (NASDAQ:HURA), a biotechnology company focused on immuno-oncology therapies, released its second quarter results on August 14, 2025. The big headlines included the start of a
ImmuCell Posts 18% Gain in Q2
ImmuCell (NASDAQ:ICCC), a specialist in animal health products for the dairy and beef industries, issued its earnings results for the second quarter of fiscal 2025 on August 14, 2025. The company
PAVmed Revenue Jumps 513% in Q2
PAVmed (NASDAQ:PAVM), a medical technology innovator focused on minimally invasive diagnostics and digital health devices, published its earnings results on August 14, 2025. The headline news was a
SurgePays Lifeline Activations Jump
SurgePays (NASDAQ:SURG) reported its fiscal Q2 2025 earnings on August 5, 2025 (for the quarter ended June 30, 2025), with revenue rose 8.9% quarter over quarter to $11.5 million and issued revenue
Vaxart Revenue Jumps 520% in Fiscal Q2
Vaxart (OTC:VXRT), a biotechnology company focused on developing oral tablet vaccines for infectious diseases, reported its second quarter results on August 13, 2025. The standout headline was a
2 Top Artificial Intelligence Stocks to Buy Right Now
It's been another banner year for artificial intelligence (AI) stocks. As of this writing, leaders like Palantir Technologies and Advanced Micro Devices advanced 148% and 44% year to date,
Pulse Biosciences Cash Jumps in Q2
Pulse Biosciences (NASDAQ:PLSE), a medical device innovator focused on nanosecond pulsed field ablation (nsPFA) for treating various conditions, released its second-quarter 2025 results on August
EQS-News: Newron begins enrollment in pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)
Massive News for AMD and Nvidia Stock Investors
In this video, I cover recent updates regarding Advanced Micro Devices (NASDAQ: AMD) and Nvidia. Watch the short video to learn more, consider subscribing, and click the special offer link below.
U.S. Reportedly Taking 15% Cut of NVDA and AMD China Sales
In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA) and Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the
EQS-News: Newron notes the publication of new preclinical research suggesting evenamide ameliorates schizophrenia-related dysfunction
AMD Shares Sink Despite Strong Growth. Is It Time to Buy the Dip?
After being a laggard to start the year, Advanced Micro Devices (NASDAQ: AMD) has rallied strongly during the summer. However, its shares took a dip following the announcement of its second-quarter
Parks America Posts Q3 Profit Surge
Parks! America (OTC:PRKA), an operator of three regional safari parks in Georgia, Missouri, and Texas, reported earnings for its fiscal third quarter on August 8, 2025, with income before income
5 Stocks to Buy on a Pullback
Valuations have been a concern for many investors across the board, but as investors, we should constantly be putting in the work so that we are prepared for when opportunities persist.
In today's
Should You Buy AMD Stock on the Dip?
Advanced Micro Devices (NASDAQ: AMD) reported quarterly financial results that disappointed stock market investors.
*Stock prices used were the afternoon prices of Aug. 4, 2025. The video was
Here's Why I Remain Bullish on AMD Despite the Dip After Earnings
In this video, I will go over Advanced Micro Devices' (NASDAQ: AMD) earnings report and explain what the market missed and why I remain extremely bullish. Watch the short video to learn more
Opinion: This Was the Last Mediocre Quarter for AMD Before the AI Story Begins
In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the special offer link below.
ORGO Sales Drop 23%
Organogenesis (NASDAQ:ORGO), a regenerative medicine company specializing in advanced wound care and surgical and sports medicine products, reported Q2 2025 results on August 7, 2025. The standout